Upstream Bio, Inc. financial statements
Upstream Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 2.85M | 10-K |
| Net income | −USD 143.44M | 10-K |
| Cash and equivalents | USD 101.58M | 10-Q |
| Total debt | USD 1.27M | EODHD |
Upstream Bio, Inc. financials on 6ix · Upstream Bio, Inc. on 6ix